IDXX Stock Summary and Trading Ideas (Idexx Laboratories | NASDAQ:IDXX)

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Idexx Laboratories trades on the NASDAQ stock market under the symbol IDXX.

As of April 19, 2024, IDXX stock price declined to $476.35 with 508,772 million shares trading.

IDXX has a beta of 1.81, meaning it tends to be more sensitive to market movements. IDXX has a correlation of 0.46 to the broad based SPY ETF.

IDXX has a market cap of $39.58 billion. This is considered a Large Cap stock.

Last quarter Idexx Laboratories reported $902 million in Revenue and $2.32 earnings per share. This beat revenue expectation by $10 million and exceeded earnings estimates by $.20.

In the last 3 years, IDXX stock traded as high as $706.95 and as low as $317.06.

The top ETF exchange traded funds that IDXX belongs to (by Net Assets): VTI, VOO, QQQ, VO, SPY.

IDXX has underperformed the market in the last year with a price return of -1.2% while the SPY ETF gained +21.2%. IDXX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -9.3% and -8.1%, respectively, while the SPY returned +4.3% and -3.5%, respectively.

IDXX support price is $470.42 and resistance is $485.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that IDXX stock will trade within this expected range on the day.